LVTX logo

LAVA Therapeutics NV (LVTX) Interest Expense

Annual Interest Expense

$232.00 K
+$150.00 K+182.93%

December 31, 2023

Summary

Performance

1-Year Change

+182.93%

3-Year Change

-32.16%

5-Year Change

+169.77%

15-Year Change

+169.77%

LVTX Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

24.13%
LVTX annual interest expense is higher than 24.13% of companies in Healthcare sector

High & Low

All-time High

$625.00 K
LVTX annual interest expense is currently -62.88% below its historical high of $625.00 thousand

3-Year Low

$82.00 K
LVTX annual interest expense is currently +182.93% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
LVTX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 20, 2025
LVTX next annual earnings announcement is scheduled for Mar 20, 2025

OtherLVTXexpensesmetrics:

Annual Total Expenses

$50.02 M
LVTX annual total expenses is $50.02 million

Annual Operating Expenses

$46.54 M
LVTX annual total operating expenses is $46.54 million

Annual Cost Of Goods Sold

$3.48 M
LVTX annual cost of goods sold is $3.48 million

Annual Income Tax

$279.00 K
LVTX annual income tax is $279.00 thousand

Quarterly Interest Expense

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

LVTX Quarterly Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$187.00 K
LVTX quarterly interest expense is currently at an all-time high

3-Year Low

-
LVTX quarterly interest expense 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LVTX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 20, 2025
LVTX next earnings announcement is scheduled for Mar 20, 2025

OtherLVTXexpensesmetrics:

Quarterly Total Expenses

$11.29 M
LVTX quarterly total expenses is $11.29 million

Quarterly Operating Expenses

$11.29 M
LVTX quarterly total operating expenses is $11.29 million

Quarterly Cost Of Goods Sold

-
LVTX quarterly cost of goods sold value is unknown

Quarterly Income Tax

$96.00 K
LVTX quarterly income tax is $96.00 thousand

TTM Interest Expense

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

LVTX TTM Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$531.20 K
LVTX TTM interest expense is currently at an all-time high

3-Year Low

-
LVTX TTM interest expense 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LVTX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 20, 2025
LVTX next earnings announcement is scheduled for Mar 20, 2025

OtherLVTXexpensesmetrics:

Annual Total Expenses

$50.02 M
LVTX annual total expenses is $50.02 million

Annual Operating Expenses

$46.54 M
LVTX annual total operating expenses is $46.54 million

TTM Cost Of Goods Sold

-
LVTX TTM cost of goods sold value is unknown

TTM Income Tax

$311.00 K
LVTX TTM income tax is $311.00 thousand

Interest Expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

LVTX Interest Expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+182.9%--
3 y3 years-32.2%--
5 y5 years+169.8%--

LVTX Interest Expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-62.9%+182.9%
5 y5-year-62.9%+182.9%
alltimeall time-62.9%+182.9%

LAVA Therapeutics NV Interest Expense History

DateAnnualQuarterlyTTM
Dec 2023
$232.00 K(+182.9%)
-
-
Dec 2022
$82.00 K(-86.9%)
-
-
Dec 2021
$625.00 K(+82.7%)
-
-
Jun 2021
-
$187.00 K(+45.0%)
$531.20 K(+30.1%)
Mar 2021
-
$129.00 K(+20.3%)
$408.30 K(+21.7%)
DateAnnualQuarterlyTTM
Dec 2020
$342.00 K(+297.7%)
$107.20 K(-0.7%)
$335.60 K(+46.9%)
Sep 2020
-
$108.00 K(+68.5%)
$228.40 K(+89.7%)
Jun 2020
-
$64.10 K(+13.9%)
$120.40 K(+113.9%)
Mar 2020
-
$56.30 K
$56.30 K
Dec 2019
$86.00 K
-
-

FAQ

  • What is LAVA Therapeutics NV annual interest expense?
  • What is the all time high annual interest expense for LAVA Therapeutics NV?
  • What is LAVA Therapeutics NV annual interest expense year-on-year change?
  • What is the all time high quarterly interest expense for LAVA Therapeutics NV?
  • What is the all time high TTM interest expense for LAVA Therapeutics NV?

What is LAVA Therapeutics NV annual interest expense?

The current annual interest expense of LVTX is $232.00 K

What is the all time high annual interest expense for LAVA Therapeutics NV?

LAVA Therapeutics NV all-time high annual interest expense is $625.00 K

What is LAVA Therapeutics NV annual interest expense year-on-year change?

Over the past year, LVTX annual interest expense has changed by +$150.00 K (+182.93%)

What is the all time high quarterly interest expense for LAVA Therapeutics NV?

LAVA Therapeutics NV all-time high quarterly interest expense is $187.00 K

What is the all time high TTM interest expense for LAVA Therapeutics NV?

LAVA Therapeutics NV all-time high TTM interest expense is $531.20 K